Journal: BMC oral health

Article Title: Salivary EGF: EGFR ratio as potential early diagnostic biomarker for oral cancer detection in tobacco chewers: a preliminary cross-sectional study.

doi: 10.1186/s12903-025-05982-8

Figure Lengend Snippet: Fig. 2 Gene expression patterns of EGF and EGFR across normal (grey box) and HNSC tumour tissues (red box) as determined by the GEPIA2 platform

Article Snippet: Salivary EGF and EGFR levels were quantified using commercially available sandwich ELISA kits: Human EGF (AssayMaxTM, Assaypro, USA) and Human EGFR (Booster Biological Technology Co., Ltd., USA) (Fig. 1).

Techniques: Gene Expression

Journal: BMC oral health

Article Title: Salivary EGF: EGFR ratio as potential early diagnostic biomarker for oral cancer detection in tobacco chewers: a preliminary cross-sectional study.

doi: 10.1186/s12903-025-05982-8

Figure Lengend Snippet: Fig. 3 Salivary EGF (A), EGFR (B) and EGF: EGFR (C) levels in HC, TC, and OSCC. p < 0.001***, p < 0.01**and p < 0.05* were considered to be statistically significant, whereas p > 0.05 considered non-significant (ns)

Article Snippet: Salivary EGF and EGFR levels were quantified using commercially available sandwich ELISA kits: Human EGF (AssayMaxTM, Assaypro, USA) and Human EGFR (Booster Biological Technology Co., Ltd., USA) (Fig. 1).

Techniques:

Journal: BMC oral health

Article Title: Salivary EGF: EGFR ratio as potential early diagnostic biomarker for oral cancer detection in tobacco chewers: a preliminary cross-sectional study.

doi: 10.1186/s12903-025-05982-8

Figure Lengend Snippet: Fig. 4 ROC (Receiver Operator Characteristic) curve analysis for diagnostic power of salivary biomarkers, EGF, EGFR, EGF: EGFR, (A) OSCC vs. HC, (B) TC vs. HC (C) OSCC vs. TC. The small hollow orange circles typically indicate the parameter values corresponding to the Youden index on the respective ROC curve

Article Snippet: Salivary EGF and EGFR levels were quantified using commercially available sandwich ELISA kits: Human EGF (AssayMaxTM, Assaypro, USA) and Human EGFR (Booster Biological Technology Co., Ltd., USA) (Fig. 1).

Techniques: Diagnostic Assay

Journal: Indian Journal of Pharmaceutical Sciences

Article Title: Protective Effects of Ginsenoside Rb1 in Rats with Diabetic Cardiomyopathy

doi: 10.36468/pharmaceutical-sciences.967

Figure Lengend Snippet: Fig. 4: Ginsenoside Rb1 attenuated inflammation and suppressed the HB-EGF pathway in DCM rats, (A): RNA expressions of IL6 as determined by quantitative real-time RT-PCR; (B): Protein expressions of HB-EGF in serum as determined by ELISA and (C): Protein expressions of HB-EGF in heart tissue as determined by Western blot Note: Compared to NC, ***p<0.001 and compared to DCM, ###p<0.001

Article Snippet: Human Heparin-Binging Epidermal Growth Factor (HB-EGF) Enzyme-Linked Immunosorbent Assay (ELISA): A Human HB-EGF ELISA kit (Elabscience, China) was used to test for the activity of HB-EGF in plasma, according to the manufacturer’s instructions.

Techniques: Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Western Blot

Journal: International Journal of General Medicine

Article Title: Characterization of Gastric Mucinous Carcinoma: Clinicopathological Insights and Vascular Features via MSCT

doi: 10.2147/IJGM.S567353

Figure Lengend Snippet: Immunohistochemistry (IHC) detection of vascular endothelial growth factor A (VEGF-A), hypoxia-inducible factor-1α (HIF-1α), and epidermal growth factor (EGF) in carcinomas and corresponding paracancerous normal tissues of MGC, LEMPC, and NMGC. ( A – C ) Representative immunohistochemical staining of VEGF-A ( A ), HIF-1α ( B ), EGF( C ) in carcinomas and normal tissues (×400, bar = 50μm). ( D – F ) IHC score differences (cancer tissue score - normal tissue score) for VEGF-A ( D ) HIF-1α ( E ) EGF ( F ) among the three groups. Statistical significance is indicated as follows: P < 0.05; P < 0.001.

Article Snippet: Sections were stained for CD34 (1:2500, Abcam, ab81289), VEGF-A (1:800, Proteintech, 66828-1-IG), HIF-1α (1:200, Proteintech, 20960-1-AP), and EGF (1:200, Proteintech, 27141-1-AP).

Techniques: Immunohistochemistry, Immunohistochemical staining, Staining